Myriad Genetics, Inc. (LON:0K3W)
London · Delayed Price · Currency is GBP · Price in USD 7.24
-0.05 (-0.75%)
At close: Dec 5, 2025
Myriad Genetics Employees
Myriad Genetics had 2,700 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2,700
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
227.40K GBP
Profits / Employee
-110.35K GBP
Market Cap
496.03M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,700 | 0 | - |
| Dec 31, 2023 | 2,700 | 100 | 3.85% |
| Dec 31, 2022 | 2,600 | 200 | 8.33% |
| Dec 31, 2021 | 2,400 | -300 | -11.11% |
| Dec 31, 2020 | 2,700 | 0 | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Spire Healthcare Group | 15,703 |
| Convatec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
Myriad Genetics News
- 12 days ago - Myriad Genetics partners to use AI to measure breast cancer risk - Seeking Alpha
- 12 days ago - Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health - GlobeNewsWire
- 26 days ago - Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences - GlobeNewsWire
- 27 days ago - Myriad Genetics (MYGN) Broadens MyRisk Cancer Test with New Gene Inclusions - GuruFocus
- 4 weeks ago - Vanguard Group Inc Reduces Stake in Myriad Genetics Inc - GuruFocus
- 4 weeks ago - Myriad Genetics: Downgrading To "Hold" Rating On Break-Even Q3 Earnings - Seeking Alpha
- 4 weeks ago - TD Cowen Raises Myriad Genetics (MYGN) Price Target to $9.00 | MYGN Stock News - GuruFocus
- 4 weeks ago - Myriad Genetics Inc (MYGN) Q3 2025 Earnings Call Highlights: Navigating Revenue Decline with ... - GuruFocus